See also this year's filing and all EDGAR filings for this company.
PDF Report 0000907654_2014_Oruka_Therapeutics_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.7485711204572415, 'aggregate_val': 4663000, 'exp_sum': 18546000, 'exp_to_value': {'GeneralAndAdministrativeExpense': 4012000, 'ResearchAndDevelopmentExpense': 2928000, 'remainder_Expenses': 11606000}} |
Graph
Absolute values for 0000907654, Oruka Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 1,502,000 |
| 2 | remainder_Liabilities | 1,000 |
| 3 | AssetsCurrent | 16,925,000 |
| 4 | AssetsNoncurrent | 130,000 |
| 5 | PropertyPlantAndEquipmentNet | 29,000 |
| 6 | Goodwill | 0 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 4,012,000 |
| 9 | ResearchAndDevelopmentExpense | 2,928,000 |
| 10 | remainder_Expenses | -2,277,000 |
| 11 | remainder_Revenues | 5,000 |
| 12 | remainder_NetIncome | 27,282,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 1,503,000 |
| 1 | Assets | 17,084,000 |
| 2 | Expenses | 4,663,000 |
| 3 | Revenues | 5,000 |
| 4 | StockholdersEquity | 15,581,000 |
| 5 | NetIncome | 22,624,000 |
| 6 | ComprehensiveNetIncome | 22,624,000 |
| 7 | BaseVar | 25,268,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.73 |
| 9 | EconomicCapitalRatio | 4.74 |
Edgar->Model Mapping
Feature Distribution
Change over Time
